PCO25-210: Design of Novel Antibody Drug Conjugates Using a Fully Humanized Monoclonal Antibody Targeting the Human Neuronal Pentraxin Receptor (YB800-ADCs) for Therapeutic Intervention in Oncology.

Peter Schiemann, Michel Janicot, Gunther Wennemuth, Mykola Lyndin, Janine Moyer
Author Information
  1. Peter Schiemann: 1Ymmunobio AG, Riehen, Switzerland.
  2. Michel Janicot: 1Ymmunobio AG, Riehen, Switzerland.
  3. Gunther Wennemuth: 2Department of Anatomy, University Hospital Essen, Essen, Germany.
  4. Mykola Lyndin: 2Department of Anatomy, University Hospital Essen, Essen, Germany.
  5. Janine Moyer: 2Department of Anatomy, University Hospital Essen, Essen, Germany.

Abstract

No abstract text available.

Word Cloud

Created with Highcharts 10.0.0AntibodyPCO25-210:DesignNovelDrugConjugatesUsingFullyHumanizedMonoclonalTargetingHumanNeuronalPentraxinReceptorYB800-ADCsTherapeuticInterventionOncology

Similar Articles

Cited By